Aquestive Therapeutics Inc stock is traded at $3.66, with a volume of 3,250,985. It is down -3.68% in the last 24 hours and down -19.91% over the past month. Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Previous Close:
$3.80
Open:
$3.84
24h Volume:
3,250,985
Relative Volume:
1.50
Market Cap:
$460.02M
Revenue:
$50.27M
Net Income/Loss:
-$68.91M
P/E Ratio:
-
EPS:
-$0.603
Net Cash Flow:
-$44.32M
1W Performance:
-9.41%
1M Performance:
-19.91%
6M Performance:
-12.44%
1Y Performance:
-39.00%
1-Day Range:
$3.60$3.85
1-Week Range:
$3.60$4.05
52-Week Range:
$2.93$6.85
Aquestive Therapeutics Inc Stock (AQST) Company Profile
Name
Aquestive Therapeutics IncSector
HealthcarePhone
908-941-1900Address
30 TECHNOLOGY DRIVE, WARREN, NJ, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS